Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl- (2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing

Journal of Korean Medical Science

Volumn 22, Issue 5, 2007, Pages 784-790

  Sun, Min Lee ^a   Jeong, Man Kim ^b   Jeong, Joseph ^c   Young, Kil Park ^d   Bai, Gill Han ^d   Eun, Yup Lee ^a   Min, Ki Lee ^a   Chang, Chulhun L ^a,d,e  

^a Pusan National University School of Medicine   (South Korea)

^b Dong A University   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d Korean Institute of Tuberculosis   (South Korea)

^e Pusan National University   (South Korea)

Author keywords

Colorimetry; Microbial sensitivity tests; Mycobacteria, atypical; Mycobacterium abscessus; Mycobacterium fortuitum

Indexed keywords

EID: 36148985317     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.5.784     Document Type: Article

References (33)

1. Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review. Infection 2004; 32: 257-70.
2. Choudhri S, Manfreda J, Wolfe J, Parker S, Long R. Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 1995; 21: 128-33.
3. Hosker HS, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995; 89: 3-8.
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: 553-67.
5. Scientific Committee in Korean Academy of Tuberculosis and Respiratory diseases. National survey of mycobacterial diseases other than tuberculosis in Korea. Tuberc Respir Dis 1995; 42: 277-94.
6. Lee JY, Choi HJ, Lee HY, Joung EY, Huh JW, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS. Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea. Tuberc Respir Dis 2005; 58: 385-91.
7. Koh WJ, Kwon OJ, Lee KS. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol 2002; 3: 145-57.
8. Lew WJ. Clinical manifestations and epidermiology of nontuberculous mycobacterial infection in Korea. Tuberc Respir Dis 2002; 53: 83-7.
9. Griffith DE. Mycobacteria as pathogens of respiratory infection. Infect Dis Clin North Am 1998; 12: 593-611.
10. Lee HW, Kim MN, Shim TS, Bia GH, Pai CH. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients. Tuberc Respir Dis 2002; 53: 173-82.
11. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006; 129: 341-8.
12. Yim JJ, Han SK. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases. J Korean Med Assoc 2005; 48: 563-70.
13. Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.
14. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156: 1-25.
15. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Norcardiae, and Other Aerobic Actinomycetes; Approved Standard. CLSI document M24-A. Wayne, Pa. USA: CLSI; 2003.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI document M100-S15. Wayne, Pa. USA: CLSI; 2005.
17. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-sixth edition. CLSI document M7-A6. Wayne, Pa. USA: CLSI; 2003.
18. Yamane N, Oiwa T, Kiyota T, Saitoh H, Sonoda T, Tosaka M, Nakashima M, Fukunaga H, Masaki T, Miyagawa K, Miyagoe M, Okazawa Y. Multicenter evaluation of a colorimetric microplate antimycobacterial susceptibility test: comparative study with the NCCLS M24-P. Rinsho Byori 1996; 44: 456-64.
19. Lee S, Kong DH, Yun SH, Lee KR, Lee KP, Franzblau SG, Lee EY, Chang CL. Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-( 2)-tetrazolium chloride. J Microbiol Methods 2006; 66: 548-51.
20. Shin JH, Choi JC, Lee JN, Kim HH, Lee EY, Chang CL. Evaluation of a colorimetric antifungal susceptibility test by using 2,3-diphenyl-5-thienyl-(2)- tetrazolium chloride. Antimicrob Agents Chemother 2004; 48: 4457-9.
21. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol 2000; 38: 2966-71.
22. Butler WR, Jost KC Jr, Kilburn JO. Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol 1991; 29: 2468-72.
23. Butler WR, Floyd MM, Silcox V, Cage G, Desmond E, Duffey PS, Guthertz LS, Gross WM, Kenneth C, Jost J, Ramos LS, Thibert L, Warren N. Mycolic acid pattern standards for HPLC identification of mycobacteria. Atlanta: Centers for Deasese Control and Prevention; 1999.
24. Clinical and Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and quality controls parameters, Approved guideline M23-A2. Wayne: CLSI; 2001.
25. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonaelike organisms. Antimicrob Agents Chemother 1992; 36: 180-4.
26. Wallace RJ Jr, Bedsole G, Sumter G, Sanders CV, Steele LC, Brown BA, Smith J, Graham DR. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990; 34: 65-70.
27. Woods GL. Susceptibility testing for mycobacteria. Clin Infect Dis 2000; 31: 1209-15.
28. Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ Jr. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 1999; 37: 1676-82.
29. Rahman M, Kuhn I, Rahman M, Olsson-Liljequist B, Mollby R. Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteria. Appl Environ Microbiol 2004; 70: 2398-403.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
31. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 1991; 142: 257-65.
32. Garn H, Krause H, Enzmann V, Drossler K. An improved MTT assay using the electron-coupling agent menadione. J Immunol Methods 1994; 168: 253-6.
33. Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450-2.